Amarantus Bioscience, Inc. (OTC:AMBS) Reports Positive Trial Results
We have been waiting for a couple of weeks for Amarantus Bioscience, Inc. (OTC:AMBS) to choose a direction, and while the ticker has been stagnant for a while, the company is pointing to developments...